Home/Memgen/Robert Coates, PhD
RC

Robert Coates, PhD

Chief Operating Officer, Chairman of the Board

Memgen

Therapeutic Areas

Memgen Pipeline

DrugIndicationPhase
MEM-288Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)Phase 1